Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene

S Capellari1, F Cardone, S Notari

  • 1Dipartimento di Scienze Neurologiche, Università di Bologna, Bologna, Italy.

Neurology
|March 9, 2005
PubMed

Insights

Researchers studied a Creutzfeldt-Jakob disease (CJD) patient with a R208H prion protein (PrP) mutation. The mutation appears to increase susceptibility to CJD without altering the disease

Area of Science:

  • Neurodegenerative diseases
  • Prion biology
  • Human genetics

Background:

  • Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal neurodegenerative disorder.
  • The prion protein gene (PRNP) encodes the prion protein (PrP).
  • Genetic variations in PRNP can influence CJD susceptibility and phenotype.

Observation:

  • A patient presented with clinical and pathological features typical of the MM1 subtype of sporadic CJD.
  • This patient, however, possessed a heterozygous R208H substitution in the PRNP gene.
  • Pathologic prion protein (PrPSc) was detected originating from both the wild-type and the mutated PRNP alleles.

Findings:

  • The PrPSc in the patient exhibited characteristics consistent with PrPSc type 1, irrespective of its allele of origin.
  • The R208H mutation did not alter the fundamental properties of the pathogenic PrPSc.
  • The patient's phenotype remained indistinguishable from common forms of sporadic CJD.

Implications:

  • The R208H mutation may confer susceptibility to developing sporadic CJD.
  • This genetic variation appears to influence disease risk rather than modifying the core characteristics of the prion agent.
  • Further research is needed to fully elucidate the role of PRNP mutations in prion disease pathogenesis.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life